Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection.

Autor:	Nakajima I; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Narui R; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Tokutake K; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Norton CA; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Stevenson WG; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Richardson TD; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Ellis CR; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Crossley GH 3rd; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Montgomery JA; Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: jay.a.montgomery@vumc.org.
Jazyk:	angličtina
Zdroj:	Heart rhythm [Heart Rhythm] 2021 May; Vol. 18 (5), pp. 752-759. Date of Electronic Publication: 2020 Dec 13.
DOI:	10.1016/j.hrthm.2020.12.011
Abstrakt:	Background: Staphylococcus bacteremia (SB) in the presence of a cardiac implantable electronic device (CIED) is frequently associated with CIED infection. In patients without clear CIED infection but SB, the role of empirical CIED removal is unclear. Objective: The purpose of this study was to describe the natural history of SB in the setting of a CIED and the effect of CIED removal on mortality in patients with concurrent SB without evidence of CIED infection. Methods: Three hundred sixty consecutive patients (mean age 61 ± 17 years; 255 (71%) men; 329 (92%) Staphylococcus aureus) with a CIED and concurrent SB were reviewed. Results: At the initial presentation with SB, 178 patients had no evidence of CIED infection. Of these, 132 (74%) had another identified source of infection. Among the 178 patients without CIED infection, 18 (10%) had empirical CIED removal during the initial bacteremia. Among those who did not undergo CIED removal, SB subsequently relapsed in 19% and relapse rates were not different for those with or without another identifiable source at the initial presentation. Relapse was strongly associated with the duration of SB >1 day (odds ratio 9.99; 95% confidence interval 3.24-30.86). Despite the absence of CIED infection, 1-year mortality was 35% and empirical device removal during the initial presentation was associated with survival benefit (hazard ratio 0.28; 95% confidence interval 0.08-0.95). Conclusion: For patients with SB without evidence of CIED infection, relapse is predicted by the duration of bacteremia. Empirical CIED removal appears to be associated with a survival benefit, although there are likely clinical situations in which this could be deferred. (Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu